LDL receptor-related protein 5
The LRP5 encodes an LDL receptor which internalizes bound LDL particles by endocytosis. It plays an important role in bone, liver and eye. Mutations cause various disorders of bone mineralization, exudative vitreoretinopathy 4, and in the liver the formation of multiple cysts.
Genetests:
Related Diseases:
References:
1. |
Van Wesenbeeck L et al. (2003) Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density.
|
2. |
Cui Y et al. (2011) Lrp5 functions in bone to regulate bone mass.
|
3. |
Narumi S et al. (2010) Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray.
|
4. |
Yadav VK et al. (2008) Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.
|
5. |
Qin M et al. (2008) Moderate reduction of Norrin signaling activity associated with the causative missense mutations identified in patients with familial exudative vitreoretinopathy.
|
6. |
Guo YF et al. (2006) Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study.
|
7. |
Clément-Lacroix P et al. (2005) Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice.
|
8. |
Ai M et al. (2005) Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.
|
9. |
Qin M et al. (2005) Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes.
|
10. |
Semënov M et al. (2005) SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor.
|
11. |
Jiao X et al. (2004) Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5.
|
12. |
Ferrari SL et al. (2004) Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites.
|
13. |
Toomes C et al. (2004) Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q.
|
14. |
Mizuguchi T et al. (2004) LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density.
|
15. |
Kondo H et al. (2003) Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity.
|
16. |
Fujino T et al. (2003) Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion.
|
17. |
Magoori K et al. (2003) Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E.
|
18. |
None (1995) Familial exudative vitreoretinopathy.
|
19. |
Shastry BS et al. (1997) Familial exudative vitreoretinopathy: further evidence for genetic heterogeneity.
|
20. |
Hey PJ et al. (1998) Cloning of a novel member of the low-density lipoprotein receptor family.
|
21. |
Dong Y et al. (1998) Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity.
|
22. |
de Crecchio G et al. (1998) Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity.
|
23. |
Chen D et al. (1999) Molecular cloning of mouse Lrp7(Lr3) cDNA and chromosomal mapping of orthologous genes in mouse and human.
|
24. |
Mao J et al. (2001) Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway.
|
25. |
Twells RC et al. (2001) The sequence and gene characterization of a 400-kb candidate region for IDDM4 on chromosome 11q13.
|
26. |
Gong Y et al. (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.
|
27. |
Little RD et al. (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait.
|
28. |
Kato M et al. (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor.
|
29. |
Boyden LM et al. (2002) High bone density due to a mutation in LDL-receptor-related protein 5.
|
30. |
Twells RC et al. (2003) Haplotype structure, LD blocks, and uneven recombination within the LRP5 gene.
|
31. |
Orphanet article
Orphanet ID 123115
|
32. |
NCBI article
NCBI 4041
|
33. |
OMIM.ORG article
Omim 603506
|
34. |
Wikipedia article
Wikipedia EN (LRP5)
|
Update: Aug. 14, 2020